Replies to post #995 on Armata Pharmaceuticals, Inc. (ARMP)

[longmike2]

H.C. WAINWRIGHT INITIATES COVERAGE ON AMPLIPHI BIOSCIENCES WITH BUY RATING, ANNOUNCES $5.00 PRICE TARGET

Font size: A | A | A


7:03 AM ET 8/28/17 | CFRA
H.C. Wainwright initiates coverage on Ampliphi Biosciences (NYSE:APHB) with a Buy rating and a $5.00 price target. Acquire Media